Clinical Trials
15 trialsNCT03258554 2026-06-02
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT04251949 2026-03-18
MuciLight
Centre Oscar Lambret
Phase 2 Completed
NCT04696744 2026-03-11
CTCO
Hospices Civils de Lyon
Completed
NCT02589938 2026-02-27
ACUPUNCTURE
Wake Forest University Health Sciences
Phase NA Completed
NCT03656133 2026-02-20
Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT03082534 2026-01-28
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
Phase 2 Completed
NCT07347899 2026-01-16
speech omics
Hospital of Stomatology, Sun Yat-Sen University
Completed
NCT07337122 2026-01-13
Collagen Matrix in Oral Cancer Surgery
Hôpital de la Croix-Rousse
Completed
NCT04580446 2025-12-15
HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT05055206 2025-12-03
Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers
University Health Network, Toronto
Phase NA Completed
NCT02918955 2025-11-20
UPFRONT-NECK
Insel Gruppe AG, University Hospital Bern
Phase 3 Completed
NCT02586207 2025-10-07
Pembrolizumab in Combination With CRT for LA-SCCHN
Sanford Health
Phase 1 Completed
NCT04180215 2025-09-15
A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers
Hookipa Biotech GmbH
Phase 1/2 Completed
NCT04952922 2025-08-08
FUNQOLR
Royal Marsden NHS Foundation Trust
Completed